Clinical Trial Update: Basiliximab Maintenance in Ulcerative Colitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Basiliximab maintenance in Ulcerative Colitis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Simulect (Basiliximab)

Snippet

Sponsor: Cerimon Pharmaceuticals | Conditions: Ulcerative Colitis | Phase 2 | Status: TERMINATED